USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Argus Pharmaceuticals Inc
Address:
3400 Research Forest Drive
The Woodlands, TX 77381
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $147,295.00 3

Award List:

ISOLATION AND EXPRESSION OF CDNA CLONES FOR RIF

Award Year / Program / Phase:
1991 / SBIR / Phase I
Award Amount:
$49,233.00
Agency:
HHS
Principal Investigator:
Tucker, Stanley D , Principal Investigator
Abstract:
Cytotoxic activated macrophages secrete soluble factors that have a variety of effects on tumor cells. included in the tumor cell response are the inhibition of mitochondrial respiration and inhibition of dna synthesis. a monokine called rif, which was found to reproduce these effects in vitro, has… More

FEASIBILITY OF PRECLINICAL SCALEUP OF LIPOSOMAL TNF

Award Year / Program / Phase:
1992 / SBIR / Phase I
Award Amount:
$48,158.00
Agency:
HHS
Principal Investigator:
Alan C Hayman
Abstract:
In this phase i effort, we will demonstrate the ability to scale up the production of a lead liposomal formulation candidate of acylated, lipophilic rhutnf. we will subject the bacterial recombinant protein to acylation with the n-hydroxysuccunimide ester of caprylic acid (c3) to achieve limited… More

DEVELOPMENT OF OPTIMUM CONDITIONS FOR NIMC PRODUCTION

Award Year / Program / Phase:
1992 / SBIR / Phase I
Award Amount:
$49,904.00
Agency:
HHS
Principal Investigator:
Alan C Hayman
Abstract:
Mitochondrial respiration inhibition in tumor cells may occur in two manners. one mechanism involves the synthesis of nitric oxide (no) by macrophages or ifn-gamma mediated induction of no synthesis in tumor cells. we have recently established a murine macrophage cell line, ea13.5, that releases a… More